<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33190296</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2230</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental dermatology</Title>
          <ISOAbbreviation>Clin Exp Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Molecular epidemiology of pachyonychia congenita in the Israeli population.</ArticleTitle>
        <Pagination>
          <StartPage>663</StartPage>
          <EndPage>668</EndPage>
          <MedlinePgn>663-668</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ced.14509</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pachyonychia congenita (PC) is a rare autosomal dominant disorder featuring palmoplantar keratoderma, nail dystrophy, oral leucokeratosis, pilosebaceous cysts and natal teeth. PC results from dominant mutations in one of five genes (KRT6A, KRT6B, KRT6C, KRT16, KRT17) encoding keratin proteins.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To delineate the clinical and genetic features of PC in a series of Israeli patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used direct sequencing of genomic DNA, and also used cDNA sequencing where applicable.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We collected clinical information and molecular data in a cohort of Israeli families diagnosed with PC (n = 16). Most of the patients were Ashkenazi Jews and had a family history of PC. The most common clinical findings were painful focal plantar keratoderma (94%) accompanied by nail dystrophy (81%), pilosebaceous cysts (31%) and prenatal/natal teeth (13%). In contrast to the high prevalence of KRT6A mutations in other populations, we found that KRT16 mutations were the most common type among Israeli patients with PC (56%). Most (77%) of the Israeli patients with PC with KRT16 mutation carried the same variant (c.380G&gt;A; p.R127H) and shared the same haplotype around the KRT16 locus, suggestive of a founder effect.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The data gleaned from this study emphasizes the importance of population-specific tailored diagnostic strategies.</AbstractText>
          <CopyrightInformation>© 2020 British Association of Dermatologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pavlovsky</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-0751-4739</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peled</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-6158-1089</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samuelov</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malki</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malovitski</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Assaf</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohamad</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meijers</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eskin-Schwartz</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Genetics Institute at Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarig</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0003-2987-2091</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sprecher</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Exp Dermatol</MedlineTA>
        <NlmUniqueID>7606847</NlmUniqueID>
        <ISSNLinking>0307-6938</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005828" MajorTopicYN="N">Genetics, Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="N">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>20</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33190296</ArticleId>
        <ArticleId IdType="doi">10.1111/ced.14509</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Bowden PE, Haley JL, Kansky A et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995; 10: 363-5.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Rugg EL, Lunny DP et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995; 9: 273-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Jonkman MF, van Goor H et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson NJ, Messenger AG, Leachman SA et al. Keratin K6c mutations cause focal palmoplantar keratoderma. J Invest Dermatol 2010; 130: 425-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Leachman SA, Kaspar RL, Fleckman P et al. Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10: 3-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Liao H, Sayers JM, Wilson NJ et al. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. J Dermatol Sci 2007; 48: 199-205.</Citation>
        </Reference>
        <Reference>
          <Citation>Eliason MJ, Leachman SA, Feng BJ et al. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 2012; 67: 680-6.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Hansen CD, Eliason MJ, Smith FJ. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 2011; 131: 1015-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Israeli S, Goldberg I, Fuchs-Telem D et al. Non-syndromic autosomal recessive congenital ichthyosis in the Israeli population. Clin Exp Dermatol 2013; 38: 911-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Abu Sa'd J, Indelman M, Pfendner E et al. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol 2006; 126: 777-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Mizrachi-Koren M, Shemer S, Morgan M et al. Homozygosity mapping as a screening tool for the molecular diagnosis of hereditary skin diseases in consanguineous populations. J Am Acad Dermatol 2006; 55: 393-401.</Citation>
        </Reference>
        <Reference>
          <Citation>Zlotogora J, van Baal S, Patrinos GP. Documentation of inherited disorders and mutation frequencies in the different religious communities in Israel in the Israeli National Genetic Database. Hum Mutat 2007; 28: 944-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Ciubotaru D, Bergman R, Baty D et al. Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol 2003; 139: 498-505.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson NJ, O'Toole EA, Milstone LM et al. The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol 2014; 171: 343-55.</Citation>
        </Reference>
        <Reference>
          <Citation>Du ZF, Xu CM, Zhao Y et al. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma. Eur J Dermatol 2012; 22: 476-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Gutierrez JA, Hannoush ZC, Vargas LG et al. A novel non-sense mutation in keratin 10 causes a familial case of recessive epidermolytic ichthyosis. Mol Genet Genomic Med 2013; 1: 108-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Terron-Kwiatkowski A, van Steensel MA, van Geel M et al. Mutation S233L in the 1B domain of keratin 1 causes epidermolytic palmoplantar keratoderma with "tonotubular" keratin. J Invest Dermatol 2006; 126: 607-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuelov L, Smith FJD, Hansen CD, Sprecher E. Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol 2020; 182: 738-46.</Citation>
        </Reference>
        <Reference>
          <Citation>Israeli S, Sarig O, Garty B et al. Molecular analysis of a series of Israeli families with Comel-Netherton syndrome. Dermatology 2014; 228: 183-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Koren A, Sprecher E, Reider E, Artzi O. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma. Br J Dermatol 2020; 182: 671-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin MT, Levy ML, Bowden P et al. Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot. Exp Dermatol 1999; 8: 115-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Shamsher MK, Navsaria HA, Stevens HP et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995; 4: 1875-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Covello SP, Smith FJ, Sillevis Smitt JH et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139: 475-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Corden LD, Rugg EL et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108: 220-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Liao H, Cassidy AJ et al. The genetic basis of pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10: 21-30.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33190296</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2230</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental dermatology</Title>
          <ISOAbbreviation>Clin Exp Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Molecular epidemiology of pachyonychia congenita in the Israeli population.</ArticleTitle>
        <Pagination>
          <StartPage>663</StartPage>
          <EndPage>668</EndPage>
          <MedlinePgn>663-668</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ced.14509</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pachyonychia congenita (PC) is a rare autosomal dominant disorder featuring palmoplantar keratoderma, nail dystrophy, oral leucokeratosis, pilosebaceous cysts and natal teeth. PC results from dominant mutations in one of five genes (KRT6A, KRT6B, KRT6C, KRT16, KRT17) encoding keratin proteins.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To delineate the clinical and genetic features of PC in a series of Israeli patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used direct sequencing of genomic DNA, and also used cDNA sequencing where applicable.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We collected clinical information and molecular data in a cohort of Israeli families diagnosed with PC (n = 16). Most of the patients were Ashkenazi Jews and had a family history of PC. The most common clinical findings were painful focal plantar keratoderma (94%) accompanied by nail dystrophy (81%), pilosebaceous cysts (31%) and prenatal/natal teeth (13%). In contrast to the high prevalence of KRT6A mutations in other populations, we found that KRT16 mutations were the most common type among Israeli patients with PC (56%). Most (77%) of the Israeli patients with PC with KRT16 mutation carried the same variant (c.380G&gt;A; p.R127H) and shared the same haplotype around the KRT16 locus, suggestive of a founder effect.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The data gleaned from this study emphasizes the importance of population-specific tailored diagnostic strategies.</AbstractText>
          <CopyrightInformation>© 2020 British Association of Dermatologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pavlovsky</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-0751-4739</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peled</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-6158-1089</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samuelov</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malki</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malovitski</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Assaf</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohamad</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meijers</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eskin-Schwartz</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Genetics Institute at Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarig</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0003-2987-2091</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sprecher</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Exp Dermatol</MedlineTA>
        <NlmUniqueID>7606847</NlmUniqueID>
        <ISSNLinking>0307-6938</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005828" MajorTopicYN="N">Genetics, Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="N">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>20</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33190296</ArticleId>
        <ArticleId IdType="doi">10.1111/ced.14509</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Bowden PE, Haley JL, Kansky A et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995; 10: 363-5.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Rugg EL, Lunny DP et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995; 9: 273-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Jonkman MF, van Goor H et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson NJ, Messenger AG, Leachman SA et al. Keratin K6c mutations cause focal palmoplantar keratoderma. J Invest Dermatol 2010; 130: 425-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Leachman SA, Kaspar RL, Fleckman P et al. Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10: 3-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Liao H, Sayers JM, Wilson NJ et al. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. J Dermatol Sci 2007; 48: 199-205.</Citation>
        </Reference>
        <Reference>
          <Citation>Eliason MJ, Leachman SA, Feng BJ et al. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 2012; 67: 680-6.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Hansen CD, Eliason MJ, Smith FJ. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 2011; 131: 1015-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Israeli S, Goldberg I, Fuchs-Telem D et al. Non-syndromic autosomal recessive congenital ichthyosis in the Israeli population. Clin Exp Dermatol 2013; 38: 911-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Abu Sa'd J, Indelman M, Pfendner E et al. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol 2006; 126: 777-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Mizrachi-Koren M, Shemer S, Morgan M et al. Homozygosity mapping as a screening tool for the molecular diagnosis of hereditary skin diseases in consanguineous populations. J Am Acad Dermatol 2006; 55: 393-401.</Citation>
        </Reference>
        <Reference>
          <Citation>Zlotogora J, van Baal S, Patrinos GP. Documentation of inherited disorders and mutation frequencies in the different religious communities in Israel in the Israeli National Genetic Database. Hum Mutat 2007; 28: 944-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Ciubotaru D, Bergman R, Baty D et al. Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol 2003; 139: 498-505.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson NJ, O'Toole EA, Milstone LM et al. The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol 2014; 171: 343-55.</Citation>
        </Reference>
        <Reference>
          <Citation>Du ZF, Xu CM, Zhao Y et al. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma. Eur J Dermatol 2012; 22: 476-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Gutierrez JA, Hannoush ZC, Vargas LG et al. A novel non-sense mutation in keratin 10 causes a familial case of recessive epidermolytic ichthyosis. Mol Genet Genomic Med 2013; 1: 108-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Terron-Kwiatkowski A, van Steensel MA, van Geel M et al. Mutation S233L in the 1B domain of keratin 1 causes epidermolytic palmoplantar keratoderma with "tonotubular" keratin. J Invest Dermatol 2006; 126: 607-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuelov L, Smith FJD, Hansen CD, Sprecher E. Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol 2020; 182: 738-46.</Citation>
        </Reference>
        <Reference>
          <Citation>Israeli S, Sarig O, Garty B et al. Molecular analysis of a series of Israeli families with Comel-Netherton syndrome. Dermatology 2014; 228: 183-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Koren A, Sprecher E, Reider E, Artzi O. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma. Br J Dermatol 2020; 182: 671-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin MT, Levy ML, Bowden P et al. Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot. Exp Dermatol 1999; 8: 115-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Shamsher MK, Navsaria HA, Stevens HP et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995; 4: 1875-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Covello SP, Smith FJ, Sillevis Smitt JH et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139: 475-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Corden LD, Rugg EL et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108: 220-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Liao H, Cassidy AJ et al. The genetic basis of pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10: 21-30.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
